<?xml version="1.0" encoding="UTF-8"?>
<p id="par0170">Many anti-immune treatments, investigational clinical trials using repurposed drugs for evaluation of direct antiviral activity have already been launched, including multiple antiviral and antimalarial medicines [
 <xref rid="bib0340" ref-type="bibr">68</xref>]. A great effort has been addressed towards sharing information on biomolecular simulation data to reveal models of how the coronavirus could potentially infect human, as well as how to prevent and/or treat COVID-19 [
 <xref rid="bib0345" ref-type="bibr">69</xref>].
</p>
